$GENR GENAERA CORP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENAERA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENAERA CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in GENAERA CORP for free.
IRS Number: 133445668
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GENR
Company Address: 5110 CAMPUS DR PLYMOUTH MEETING 19462
Former name: MAGAININ PHARMACEUTICALS INC, date of change: 1993-03-28
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
GENAERA CORP Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 01 2009 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Sell | S | 0.10 | 42,571 | 4,321 | 2,795,781 | 2.8 M to 2.8 M (-1.50 %) |
| Jun 09 2009 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Sell | S | 0.31 | 1,378,723 | 426,715 | 2,838,352 | 4.2 M to 2.8 M (-32.69 %) |
| Mar 05 2009 | GENR | GENAERA CORP | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 3.66 | 210,375 | 770,099 | 411,205 | |
| Feb 23 2009 | GENR | GENAERA CORP | Kaye Mitchell D | Director | Option Exercise | J | 3.66 | 210,375 | 770,099 | 411,205 | |
| Aug 15 2008 | GENR | GENAERA CORP | Wotton Paul K | Director | Option Exercise | A | 1.53 | 17,500 | 26,775 | 17,500 | |
| Aug 15 2008 | GENR | GENAERA CORP | SHAPIRO ROBERT F | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
| Aug 15 2008 | GENR | GENAERA CORP | Kaye Mitchell D | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
| Aug 15 2008 | GENR | GENAERA CORP | IMASOGIE OSAGIE O | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
| Aug 15 2008 | GENR | GENAERA CORP | HOROVITZ ZOLA P | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
| Aug 15 2008 | GENR | GENAERA CORP | ECOCK R FRANK | Director | Option Exercise | A | 1.53 | 35,000 | 53,550 | 35,000 | |
| Aug 13 2008 | GENR | GENAERA CORP | Wolfe Henry R | EVP & Chief Scienti ... | Option Exercise | A | 1.68 | 300,000 | 504,000 | 300,000 | |
| Aug 13 2008 | GENR | GENAERA CORP | Kelly Leanne M. | SVP & Chief Financi ... | Option Exercise | A | 1.68 | 300,000 | 504,000 | 300,000 | |
| Aug 13 2008 | GENR | GENAERA CORP | Gast Michael J | EVP & Chief Medical ... | Option Exercise | A | 1.68 | 300,000 | 504,000 | 300,000 | |
| Aug 13 2008 | GENR | GENAERA CORP | ARMSTRONG JOHN L JR | President and CEO | Option Exercise | A | 1.68 | 400,000 | 672,000 | 400,000 | |
| Jun 30 2008 | GENR | GENAERA CORP | Wotton Paul K | Director | Option Exercise | A | 1.83 | 3,333 | 6,099 | 3,333 |